ranolazine
Generic: ranolazine
Labeler: unichem pharmaceuticals (usa), inc.Drug Facts
Product Profile
Brand Name
ranolazine
Generic Name
ranolazine
Labeler
unichem pharmaceuticals (usa), inc.
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Routes
Active Ingredients
ranolazine 1000 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
29300-297
Product ID
29300-297_429d55c7-1e90-4345-a6d4-59f689557f40
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA213083
Listing Expiration
2026-12-31
Marketing Start
2023-03-16
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
29300297
Hyphenated Format
29300-297
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
ranolazine (source: ndc)
Generic Name
ranolazine (source: ndc)
Application Number
ANDA213083 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 1000 mg/1
Packaging
- 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (29300-297-01)
- 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (29300-297-16)
- 250 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (29300-297-52)
Packages (3)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "429d55c7-1e90-4345-a6d4-59f689557f40", "openfda": {"nui": ["N0000175427", "N0000190114", "N0000185503", "N0000182137", "N0000187061"], "unii": ["A6IEZ5M406"], "rxcui": ["616749", "728231"], "spl_set_id": ["e2a8c9f9-5f6a-4496-8fd6-2439e564db4f"], "pharm_class_epc": ["Anti-anginal [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "manufacturer_name": ["Unichem Pharmaceuticals (USA), Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (29300-297-01)", "package_ndc": "29300-297-01", "marketing_start_date": "20230715"}, {"sample": false, "description": "60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (29300-297-16)", "package_ndc": "29300-297-16", "marketing_start_date": "20230715"}, {"sample": false, "description": "250 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (29300-297-52)", "package_ndc": "29300-297-52", "marketing_start_date": "20230715"}], "brand_name": "Ranolazine", "product_id": "29300-297_429d55c7-1e90-4345-a6d4-59f689557f40", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Anti-anginal [EPC]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "29300-297", "generic_name": "Ranolazine", "labeler_name": "Unichem Pharmaceuticals (USA), Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ranolazine", "active_ingredients": [{"name": "RANOLAZINE", "strength": "1000 mg/1"}], "application_number": "ANDA213083", "marketing_category": "ANDA", "marketing_start_date": "20230316", "listing_expiration_date": "20261231"}